{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260407024140/en/Savara-Announces-the-U.K.-Medicines-and-Healthcare-Products-Regulatory-Agency-MHRA-Has-Accepted-the-MOLBREEVI*-Marketing-Authorisation-Application-MAA-for-Autoimmune-Pulmonary-Alveolar-Proteinosis-Autoimmune-PAP", "message": "News view counter 650889 successfully enlarged"}